Navigation Links
Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
Date:4/26/2010

','ExternalLink');" target='_blank' href="http://www.siriontherapeutics.com/">www.siriontherapeutics.com or call our customer support number (1-866-4SIRION).  For sample requests please call 1-888-387-0853.

About Herpetic Keratitis

Herpetic Keratitis is the number one infectious cause of corneal blindness in the U.S.  Herpes simplex virus infections are very common, with nearly 60% of the US population showing evidence of infection by age five. Approximately 1% of infected patients develop ocular outbreaks, with 20,000 primary cases of ocular herpes diagnosed in the US each year. After the primary infection, ocular HSV typically becomes latent until triggers such as stress, UV radiation, and hormonal changes reactivate the virus and cause recurrent outbreaks. Those recurrences account for an additional 28,000 cases per year in the US. The risk of blindness increases with the number and severity of recurrences, making prompt treatment imperative to limit corneal scarring and other more serious ocular complications caused by herpetic ulcers.

About Zirgan™ (ganciclovir ophthalmic gel) 0.15%

Zirgan™ (ganciclovir ophthalmic gel) 0.15% is indicated for topical ophthalmic use as a treatment for acute herpetic keratitis (dendritic corneal ulcers).  Zirgan™ is an innovative topical antiviral therapy designed to specifically target herpes virus infected cells.  Zirgan™ has been a leading treatment for corneal ulcers, under the brand name Virgan®, in Europe for more than 10 years.  

The recommended dosing for Zirgan™ is one drop five times per day until the ulcer heals, and then one drop three times per day for seven days.  Zirgan™ is indicated for topical ophthalmic use only.  Patients should n
'/>"/>

SOURCE Sirion Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Announces Positive Phase III Results for Difluprednate
2. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
3. Sirion Therapeutics Announces Positive Pivotal Uveitis Data for Durezol(TM)
4. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
9. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
10. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... OAKS, Calif. , May 22, 2015 ... announced the Company has commenced termination of ... of brodalumab with AstraZeneca (LON:AZN, STO:AZN and ... IL-17 inhibitor, is in development for patients ... axial spondyloarthritis.  The decision was based on ...
(Date:5/22/2015)... , May 22, 2015 The Assistance ... Program. This program provides financial assistance for copay to ... pleased to announce the addition of the Melanoma Copay ... Mark McGreevy , executive director. "With each additional ... vision of a world where no one is denied ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:Amgen to terminate participation in co-development and commercialization of brodalumab 2Amgen to terminate participation in co-development and commercialization of brodalumab 3Amgen to terminate participation in co-development and commercialization of brodalumab 4Amgen to terminate participation in co-development and commercialization of brodalumab 5The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... NORTH WALES, Pa., Aug. 18 AirPal ®, ... and positioning technology, has announced the expansion of its ... positioning functionality. "This announcement marks the launch ... Positioning™ systems," said Jim Weedling, President AirPal, Inc.  "Among ...
... LAUDERDALE, Fla., Aug. 18 After a lengthy ... of power mobility products and services, has selected ... to help strengthen and broaden the company,s brand ... Advertising and Daggerwing, Omnicom,s team will include Javelin ...
Cached Medicine Technology:AirPal Expands Line of Air-Activated Transfer Pads to Include Multi-Purpose Patient Positioning Functionality 2Omnicom Adds National Healthcare Giant to Client Roster 2Omnicom Adds National Healthcare Giant to Client Roster 3
(Date:5/26/2015)... Many sexy cocktail dresses inspired by celebrities have ... Now, TheCelebrityDresses.com is offering great discounts on all ... The company aims to help ladies from all ... on valuable, trendy formal outfits. , TheCelebrityDresses.com is ... occasion dresses. Their dresses are popular among both ...
(Date:5/26/2015)... U.S. Food and Drug Administration (FDA) regulations ... extensive and can be difficult to understand. Registrar ... companies comply with FDA regulations, compiled a list of ... requirements. , 1. Start researching early. Marketing ... a lengthy process depending on the classification of the ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his fellow board ... have launched a Balloon Sinuplasty website to inform potential ... the benefits of Balloon Sinuplasty. , The website includes ... someone is a good candidate for Balloon Sinuplasty. The ... can contribute to chronic nasal congestion. If the user ...
(Date:5/25/2015)... (PRWEB) May 26, 2015 The ... Hooker as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in dentistry. NAPW is ... boasting more than 700,000 members and over 200 operating ... into this exceptional group of professional women,” said NAPW ...
(Date:5/25/2015)... 25, 2015 World Patent Marketing, a ... the Hidee-Hose, an undergarment patent that allays women’s fears ... Women's Hosiery industry forecasts the market to reach $20.3 ... Creative Director of World Patent Marketing , "The ... ahead and is expected to maintain its lead. The ...
Breaking Medicine News(10 mins):Health News:Cocktail Dresses Inspired by Celebrities on Sale at TheCelebrityDresses.com 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Dr. Laquinas Hooked, D.D.S. of General Dentist, Into its VIP Professional Woman of the Year Circle 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 2Health News:For The Courtesy Of Women's Health And Looks - World Patent Marketing Presents A New Undergarment Patent 3
... such as broccoli, Brussel sprouts, cauliflower and green cabbage ... of cancer . But, researchers have now warned that ... properties. ,Brassica vegetables have a high concentration ... cancer preventive substances known as isothiocyanates. ...
... heed of, by bosses. The study shows that feelings of ... consequences, like a heart attack. ,The study ... published in the Journal of Epidemiology and Community Health tracked ... for almost 11 years. ,The researchers found that ...
... percent of U.S. adults may have some form of ... about 2.4 percent with a "sub-threshold" condition, according ... General Psychiatry. ,Individuals with bipolar disorder tend ... characterized by impulsive behavior and an increased activity leveland ...
... American research, the most effective weight-loss diet for any person ... author David Ludwig, director of the Optimal Weight for Life ... shows that one diet doesn't necessarily fit all', also notes ... their weight in their midsection lost a lot more ...
... scientists at the Georgia Institute of Technology and the Ovarian ... to be essential in helping chemotherapy kill cancer cells, may ... 70 percent of subjects whose tumors had mutations in the ... normal p53 displayed only a 30 percent survival rate. ...
... new study has shown that cigarette smoking is more strongly ... ,The study, published in the Journal of ... and neck cancers among non-drinkers was due to smoking. ... Agency for Cancer Research in Lyon, the researchers examined head ...
Cached Medicine News:Health News:Boiling Makes Broccoli to Loses Its Anticancer Properties 2Health News:Feelings Of Injustice At Work Can Lead To A Heart Attack 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 2Health News:More Than Four Percent of US Adults Have Some Form of Bipolar Disorder 3Health News:Check Your Physiology Before You Choose A Diet 2Health News:Gene Thought to Help Kill Cancer Cells may Actually Help Them Thrive 2
... 10 mm applier contains 20 titanium clips in ... clips in the L size. The appliers are ... sized Auto Suture trocar sleeves, or larger sized ... After introduction of the ENDO CLIP clip applier ...
... Multi-Use Reposable Clip Applier ... disposables with the economics ... superior instrument balance and ... cartridges. The multi-use Reposable ...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Pilling-Weck, small clip size, 10mm, rotatable take apart...
Medicine Products: